@article{ZHANG2025114383,
title = {Macrocycle-based self-assembled amphiphiles for co-delivery of therapeutic combinations to tumor},
journal = {Colloids and Surfaces B: Biointerfaces},
volume = {246},
pages = {114383},
year = {2025},
issn = {0927-7765},
doi = {https://doi.org/10.1016/j.colsurfb.2024.114383},
url = {https://www.sciencedirect.com/science/article/pii/S0927776524006428},
author = {Ziliang Zhang and Shujie Lin and Yahan Zhang and Longming Chen and Di Gao and Chengyang Tian and Junyi Chen and Qingbin Meng},
keywords = {Antitumor, Self-assembled nanoparticles, Co-delivery, Combination chemotherapy},
abstract = {For tumor treatment, the efficiency of single chemotherapeutic agent is generally limited and the traditional combination chemotherapies frequently result in the aggravation of side effects. Herein, an amphiphilic pillararene-based self-assembled nanoparticle (APSN) composed of hydrazide-pillar[5]arene (HP5A-6C) that achieve effective co-delivery of therapeutic combinations was reported. Through integrating multitudinous macrocyclic cavities into a single nanoparticle, the APSN could co-load two antitumor drugs, cisplatin (CP) and nitrogen mustard (NM) via host-guest interactions. A serious of safety tests preliminary demonstrated that blank carrier APSN had good biocompatibility. Cytotoxicity assay verified that co-delivery system CP+NM@APSN could exert a synergistic antitumor effect at the cellular level. In vivo studies demonstrated that CP+NM@APSN could not only improve chemotherapeutic outcomes in tumor-bearing model mouse but also alleviate two medications-related side effects. These favorable findings were attributed to the formation of ternary supramolecular assembly that benefited from an enhanced permeability and retention effect. Â© 2024 Elsevier Science. All rights reserved}
}